Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID-19 research v0.36 | CARD9 |
Ellen McDonagh gene: CARD9 was added gene: CARD9 was added to Viral susceptibility. Sources: Expert Review Green,ESID Registry 20171117,North West GLH,Victorian Clinical Genetics Services,GRID V2.0,NHS GMS,London North GLH,IUIS Classification February 2018 Mode of inheritance for gene: CARD9 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: CARD9 were set to 19864672; 23335372; 24131138 Phenotypes for gene: CARD9 were set to Predisposition to invasive fungal disease due to CARD9 deficiency; 212050; CARD9 deficiency; Invasive candidiasis infection, deep dermatophytoses, other invasive fungal infections; Candidiasis, familial, 2; Defects in Intrinsic and Innate Immunity |